CheckMate 067 Shows OS Improved With Nivolumab/Ipilimumab in Melanoma

A nivolumab/ipilimumab combination significantly improved overall survival for advanced melanoma patients.

Source: CancerNetwork - April 10, 2017 Category: Cancer & Oncology Authors: Mark L. Fuerst Tags: Conferences/AACR 2017 Melanoma News Source Type: news